CareDx ROE 2013-2025 | CDNA
Current and historical return on equity (ROE) values for CareDx (CDNA) over the last 10 years. Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
| CareDx ROE - Return on Equity Historical Data | |||
|---|---|---|---|
| Date | TTM Net Income | Shareholder's Equity | Return on Equity |
| 2025-03-31 | $0.06B | $0.38B | 19.46% |
| 2024-12-31 | $0.05B | $0.38B | 18.09% |
| 2024-09-30 | $-0.15B | $0.27B | -55.36% |
| 2024-06-30 | $-0.16B | $0.27B | -55.10% |
| 2024-03-31 | $-0.19B | $0.26B | -56.53% |
| 2023-12-31 | $-0.19B | $0.26B | -51.35% |
| 2023-09-30 | $-0.09B | $0.39B | -21.82% |
| 2023-06-30 | $-0.08B | $0.41B | -19.85% |
| 2023-03-31 | $-0.08B | $0.42B | -18.71% |
| 2022-12-31 | $-0.08B | $0.43B | -17.40% |
| 2022-09-30 | $-0.08B | $0.44B | -16.62% |
| 2022-06-30 | $-0.07B | $0.44B | -15.22% |
| 2022-03-31 | $-0.05B | $0.46B | -10.66% |
| 2021-12-31 | $-0.03B | $0.47B | -6.56% |
| 2021-09-30 | $-0.02B | $0.47B | -4.47% |
| 2021-06-30 | $-0.01B | $0.48B | -2.67% |
| 2021-03-31 | $-0.02B | $0.47B | -4.69% |
| 2020-12-31 | $-0.02B | $0.28B | -8.80% |
| 2020-09-30 | $-0.02B | $0.27B | -11.51% |
| 2020-06-30 | $-0.02B | $0.26B | -14.31% |
| 2020-03-31 | $-0.02B | $0.10B | -21.48% |
| 2019-12-31 | $-0.02B | $0.10B | -23.83% |
| 2019-09-30 | $-0.02B | $0.10B | -22.98% |
| 2019-06-30 | $-0.04B | $0.09B | -48.63% |
| 2019-03-31 | $-0.05B | $0.10B | -69.43% |
| 2018-12-31 | $-0.05B | $0.10B | -93.07% |
| 2018-09-30 | $-0.08B | $0.04B | -300.00% |
| 2018-06-30 | $-0.07B | $0.03B | -492.86% |
| 2018-03-31 | $-0.06B | $0.03B | -605.13% |
| 2017-12-31 | $-0.06B | $-0.01B | -1066.67% |
| 2017-09-30 | $-0.04B | $0.00B | -331.91% |
| 2017-06-30 | $-0.03B | $0.01B | -138.10% |
| 2017-03-31 | $-0.04B | $0.02B | -133.33% |
| 2016-12-31 | $-0.04B | $0.02B | -141.82% |
| 2016-09-30 | $-0.03B | $0.04B | -97.48% |
| 2016-06-30 | $-0.03B | $0.03B | -96.55% |
| 2016-03-31 | $-0.02B | $0.02B | -70.00% |
| 2015-12-31 | $-0.01B | $0.03B | -37.41% |
| 2015-09-30 | $-0.01B | $0.03B | -21.19% |
| 2015-06-30 | $0.00B | $0.04B | -10.13% |
| 2015-03-31 | $0.00B | $0.04B | 0.00% |
| 2014-12-31 | $0.00B | $0.04B | 6.25% |
| 2014-09-30 | $0.00B | $0.04B | 0.00% |
| 2014-06-30 | $0.00B | $0.00B | 24.24% |
| 2014-03-31 | $0.00B | $-0.02B | 50.00% |
| 2013-12-31 | $0.00B | $-0.02B | 106.67% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Services | $1.129B | $0.334B |
| CareDx, Inc. is a commercial stage company. It develops, markets, and delivers a diagnostic surveillance solution for heart transplant recipients. The Company provides AlloMap, a noninvasive blood test used to aid in the identification of heart transplant recipients. It is also pursuing other areas of transplant surveillance, such as the use of cell-free DNA (cfDNA) as a biomarker for rejection. CareDx, Inc. is based in Brisbane, California. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Danaher (DHR) | United States | $143.821B | 26.97 |
| CVS Health (CVS) | United States | $84.326B | 10.48 |
| Elevance Health (ELV) | United States | $78.255B | 10.10 |
| Cencora (COR) | United States | $58.178B | 20.24 |
| DiDi Global (DIDIY) | China | $23.485B | 24.95 |
| Natera (NTRA) | United States | $22.086B | 0.00 |
| Labcorp Holdings (LH) | United States | $21.684B | 17.59 |
| BioMerieux (BMXMF) | France | $16.861B | 0.00 |
| EUROFINS SCIENT (ERFSF) | Luxembourg | $13.804B | 0.00 |
| Solventum (SOLV) | United States | $12.836B | 13.59 |
| CochLear (CHEOY) | Australia | $12.824B | 0.00 |
| ICON (ICLR) | Ireland | $12.156B | 11.30 |
| Revvity (RVTY) | United States | $11.802B | 20.31 |
| Viatris (VTRS) | United States | $10.833B | 3.72 |
| Avantor (AVTR) | United States | $9.247B | 13.44 |
| Medpace Holdings (MEDP) | United States | $9.225B | 24.50 |
| HealthEquity (HQY) | United States | $8.646B | 37.87 |
| Sonic Healthcare (SKHHY) | Australia | $8.518B | 0.00 |
| Charles River Laboratories (CRL) | United States | $7.808B | 15.30 |
| Caris Life Sciences,�Inc (CAI) | United States | $6.930B | 0.00 |
| Amplifon S.p.A (AMFPF) | Italy | $5.378B | 29.44 |
| Bausch + Lomb (BLCO) | Canada | $4.971B | 29.27 |
| BrightSpring Health Services (BTSG) | United States | $3.760B | 34.50 |
| Sotera Health (SHC) | United States | $3.296B | 18.73 |
| Surgery Partners (SGRY) | United States | $2.870B | 37.32 |
| Alignment Healthcare (ALHC) | United States | $2.750B | 0.00 |
| GeneDx Holdings (WGS) | United States | $2.622B | 100.97 |
| Concentras Parent (CON) | United States | $2.619B | 15.13 |
| Organon (OGN) | United States | $2.576B | 2.74 |
| Progyny (PGNY) | United States | $2.038B | 44.87 |
| Ardent Health (ARDT) | United States | $1.981B | 8.45 |
| PACS (PACS) | United States | $1.957B | 0.00 |
| Premier (PINC) | United States | $1.778B | 13.49 |
| GoodRx Holdings (GDRX) | United States | $1.739B | 34.79 |
| Teladoc Health (TDOC) | United States | $1.553B | 0.00 |
| Establishment Labs Holdings (ESTA) | $1.303B | 0.00 | |
| Pediatrix Medical (MD) | United States | $1.165B | 8.86 |
| Ryman Healthcare (RYHTY) | New Zealand | $0.970B | 0.00 |
| Agilon Health (AGL) | United States | $0.948B | 0.00 |
| QDM (QDMI) | Hong Kong, SAR China | $0.846B | 0.00 |
| AMN Healthcare Services Inc (AMN) | United States | $0.833B | 7.80 |
| Nutex Health (NUTX) | United States | $0.643B | 9.73 |
| Embecta (EMBC) | United States | $0.619B | 4.17 |
| InnovAge Holding (INNV) | United States | $0.571B | 0.00 |
| SBC Medicals (SBC) | United States | $0.546B | 0.00 |
| LifeMD (LFMD) | United States | $0.535B | 0.00 |
| Sonida Senior Living (SNDA) | United States | $0.484B | 0.00 |
| Auna S.A (AUNA) | Luxembourg | $0.471B | 10.62 |
| So-Young (SY) | China | $0.440B | 0.00 |
| Omada Health (OMDA) | $0.434B | 0.00 | |
| Enhabit (EHAB) | United States | $0.368B | 30.29 |
| Performant Healthcare (PHLT) | United States | $0.335B | 0.00 |
| COMPASS Pathways (CMPS) | United Kingdom | $0.330B | 0.00 |
| Beauty Health (SKIN) | United States | $0.263B | 0.00 |
| Oncology Institute (TOI) | United States | $0.216B | 0.00 |
| DocGo (DCGO) | United States | $0.159B | 26.00 |
| Pheton Holdings (PTHL) | China | $0.132B | 0.00 |
| Sera Prognostics (SERA) | United States | $0.100B | 0.00 |
| KindlyMD (NAKA) | United States | $0.074B | 0.00 |
| Basel Medical Group (BMGL) | Singapore | $0.067B | 0.00 |
| IceCure Medical (ICCM) | Israel | $0.062B | 0.00 |
| NeueHealth (NEUE) | United States | $0.061B | 0.00 |
| ModivCare (MODV) | United States | $0.060B | 0.00 |
| Biodesix (BDSX) | United States | $0.046B | 0.00 |
| NeuroOne Medical Technologies (NMTC) | United States | $0.037B | 0.00 |
| OSR Holdings (OSRH) | United States | $0.024B | 0.00 |
| Intelligent Bio Solutions (INBS) | United States | $0.013B | 0.00 |
| BioNexus Gene Lab (BGLC) | $0.010B | 0.00 | |
| Co-Diagnostics (CODX) | United States | $0.009B | 0.00 |
| SeaStar Medical Holding (ICU) | United States | $0.008B | 0.00 |
| XWELL (XWEL) | United States | $0.005B | 0.00 |
| Aclarion (ACON) | United States | $0.004B | 0.00 |
| NewGenIvf Group (NIVF) | Thailand | $0.003B | 0.00 |
| ISpecimen (ISPC) | United States | $0.003B | 0.00 |
| INVO Fertility (IVF) | United States | $0.002B | 0.00 |
| Cano Health (CANOQ) | United States | $0.000B | 0.00 |